Roles of TGF β and FGF Signals in the Lens: Tropomyosin Regulation for Posterior Capsule Opacity
Overview
Chemistry
Molecular Biology
Affiliations
Transforming growth factor (TGF) β and fibroblast growth factor (FGF) 2 are related to the development of posterior capsule opacification (PCO) after lens extraction surgery and other processes of epithelial⁻mesenchymal transition (EMT). Oxidative stress seems to activate TGF β1 largely through reactive oxygen species (ROS) production, which in turn alters the transcription of several survival genes, including lens epithelium-cell derived growth factor (LEDGF). Higher ROS levels attenuate LEDGF function, leading to down-regulation of peroxiredoxin 6 (Prdx6). TGF β is regulated by ROS in Prdx6 knock-out lens epithelial cells (LECs) and induces the up-regulation of tropomyosins (Tpms) 1/2, and EMT of LECs. Mouse and rat PCO are accompanied by elevated expression of Tpm2. Further, the expression of Tpm1/2 is induced by TGF β2 in LECs. Importantly, we previously showed that TGF β2 and FGF2 play regulatory roles in LECs in a contrasting manner. An injury-induced EMT of a mouse lens as a PCO model was attenuated in the absence of Tpm2. In this review, we present findings regarding the roles of TGF β and FGF2 in the differential regulation of EMT in the lens. Tpms may be associated with TGF β2- and FGF2-related EMT and PCO development.
Fan C, Yang Y, You M, Chen Z, Jiang J Invest Ophthalmol Vis Sci. 2024; 65(14):17.
PMID: 39652067 PMC: 11629908. DOI: 10.1167/iovs.65.14.17.
Li C, Yan W, Yan H Antioxidants (Basel). 2024; 13(10).
PMID: 39456463 PMC: 11504336. DOI: 10.3390/antiox13101210.
Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.
Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomolecules. 2024; 14(9).
PMID: 39334822 PMC: 11430732. DOI: 10.3390/biom14091055.
Uzun F, Aydin E, Akgoz H, Aslan M J Inflamm Res. 2024; 17:6075-6082.
PMID: 39253563 PMC: 11382797. DOI: 10.2147/JIR.S473655.
Consilience and unity in ocular anterior segment research.
Araj H Int J Ophthalmol. 2024; 17(7):1173-1183.
PMID: 39026918 PMC: 11246940. DOI: 10.18240/ijo.2024.07.01.